Vaginal dryness, bladder leaks, painful sex, and postpartum recovery — for decades, these everyday realities were ignored by mainstream medicine and dismissed as “just part of aging.” Today, they represent one of the fastest-growing sectors in healthcare, wellness, and venture capital.
In this episode, we sit down with two trailblazing CEOs approaching the women’s intimate wellness boom from two distinct angles: Colette Courtion (Founder & CEO of Joylux) and Dawn Halkuff (CEO of LiviWell).
Together, they break down how they transitioned from personal and professional frustrations into building category-defining businesses, how the “menopause movement” is shifting consumer behavior, and the massive opportunities ahead for founders and investors in Femtech.
💡 KEY TOPICS COVERED:
• The Taboo Tax: Why women’s pelvic and intimate health was historically ignored by capital and medicine.
• Consumer vs. Medical Innovation: How Joylux’s vFit PLUS (red-light therapy) & LiviWell’s FDA-cleared Livi device (post-intercourse fluid absorption) tackle unmet needs.
• The Halle Berry Partnership: How Joylux teamed up with Halle Berry’s wellness platform, Respin, to normalize midlife intimate health.
• The Regulatory Path: What FDA clearance means for safety, consumer trust, and commercial scaling.
• The Future of Femtech: What must catch up, from insurance coverage to provider education, for the intimate wellness market to reach its multi-billion-dollar potential.
#WomensHealth #Menopause #IntimateWellness #SexualHealth #Femtech
00:00 Introduction: The women's intimate health boom
01:28 The personal catalysts: Behind the scenes of postpartum and industry gaps
12:20 Why now? The convergence of capital, culture, and consumer demand
16:09 The Viagra disparity: Why men's health got a pill and women got silenced
22:00 How it works: Red-light therapy and vaginal rejuvenation (Joylux vFit PLUS)
24:48 Halle Berry partnership with Respin
28:53 Clinical validation: Introducing Livi, the first FDA-cleared post-sex vaginal care device
33:53 Combatting the "wellness trend" stigma with hard science
38:28 Guest-to-guest Q&A and final takeaways
